/TLX

TLX

Updated 7 Oct 08:01 am

$15.87

TELIX PHARMACEUTICALS LIMITED

1D+2.99%
1M-2.34%
1Y+2.99%
Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Track your position in TLX

Sign in to TradeLedgr to record trades in TLX (TELIX PHARMACEUTICALS LIMITED) with broker-true precision and ATO-compliant reporting.

Recent Announcements

Appendix 3H (Notification of cessation of securities)
Appendix 3G
Appendix 2A
Progress Report
25 Sep 2026 8:06 AM
1194KB
Change in substantial holding
Change in substantial holding

Fundamentals

P/E Ratio

108.80x

Div Yield

0.00%

EPS

$0.1416

Avg Vol

—

52W High

$18.220

52W Low

$8.260

Company Profile

Development and commercialising molecularly targeted radiation products for the treatment of cancer.

Financial History

2025A

$-7.1M profit

$803.8M rev

2024A

$33.7M profit

$516.6M rev

2023A

$4.2M profit

$333.0M rev